CAS 132523-92-3

1-benzoyl-4-ethyl-5-[4-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)benzoyl]-1,3-dihydro-2H-imidazol-2-one

Description:

1-Benzoyl-4-ethyl-5-[4-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)benzoyl]-1,3-dihydro-2H-imidazol-2-one, with CAS number 132523-92-3, is a complex organic compound characterized by its imidazole and benzoyl functional groups. This substance features a fused imidazole ring system, which contributes to its potential biological activity, particularly in medicinal chemistry. The presence of ethyl and methyl substituents enhances its lipophilicity, potentially influencing its solubility and permeability in biological systems. The compound's structure suggests it may exhibit interesting pharmacological properties, possibly acting as an inhibitor or modulator in various biochemical pathways. Its synthesis typically involves multi-step organic reactions, highlighting the importance of careful control of reaction conditions to achieve the desired purity and yield. As with many imidazole derivatives, it may also exhibit properties such as antimicrobial or anti-inflammatory activities, making it a candidate for further research in drug development. However, specific biological activities and applications would require empirical investigation and validation through experimental studies.

Formula: C₂₃H₂₂N₄O₃

InChI: InChI=1/C23H22N4O3/c1-3-19-20(27(23(30)25-19)22(29)17-7-5-4-6-8-17)21(28)16-9-11-18(12-10-16)26-14-13-24-15(26)2/h4-12H,3,13-14H2,1-2H3,(H,25,30)

CK 3197

CAS: 132523-92-3

CK 3197 is a selective positive inotropic agent for the treatment of congestive heart failure. It has hemodynamic and myocardial energetic effects.

Formula: C₂₃H₂₂N₄O₃

Color and Shape: Solid

Molecular weight: 402.45

Ref: TM-T30956